News and Announcements
Proteomics Commences Therapeutic Drug Discovery Program
- Published March 23, 2016 1:52PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd Marc h 2016, ASX Announcement
Highlights:
- PILL to utilise its proprietary disruptive technology platform to assess potential new painkilling and antibiotic drug compounds.
- Therapeutic Drug Discovery is one of PILL’s core business areas and is a major growth market – peptide therapeutics market estimated value is $17b.
- Program is low cost and has potential deliver major end returns.
- PILL’s drug discovery process delivers a significant reduction in discovery timeline and a substantial cost advantage relative to traditional drug delivery
Life science company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce that it has commenced a Therapeutic Drug Discovery program utilising its proprietary proteomics-based technology platform.
The Company is specifically targeting the discovery of new analgesic (painkilling) and antibiotics compounds and will test 50 – 100 venoms in the program. The program is low cost to PILL, with no additional costs incurred apart from sourcing the venom samples, and has the potential deliver highly significant end returns.
To view the full article please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
